Первичное (pre-print) исследование о способности двух вакцин (Pfizer и Moderna) предложить достойный ответ различным мутациям коронавируса.
We find that although neutralization is largely preserved against many variants, those containing the K417N/T, E484K, and N501Y RBD mutations, namely, P.1 and B.1.351 variants, have significantly decreased neutralization even in fully vaccinated individuals.
B.1.351 - это так называемый "южно-африканский" штамм коронавируса.
We find that although neutralization is largely preserved against many variants, those containing the K417N/T, E484K, and N501Y RBD mutations, namely, P.1 and B.1.351 variants, have significantly decreased neutralization even in fully vaccinated individuals.
B.1.351 - это так называемый "южно-африканский" штамм коронавируса.
Comments
Be the first to add a comment
Log in to comment